Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Cincinnati Biotech Firm Moving HQ to Indiana

Abstract:
PDS Biotechnology Corporation, a developer of disease-destroying nanotechnology, announced today it will relocate its Cincinnati headquarters and laboratory here with the help of a $2 million grant from the state's 21st Century Research and Technology fund.

Cincinnati Biotech Firm Moving HQ to Indiana

INDIANAPOLIS, IN | Posted on January 21st, 2009

The biopharmaceutical company, which will locate its operations at a yet-to-be announced site in the capitol city, will bring to Indiana its Versamune™ platform technology that allows scientists to deliver targeted nanoparticles to the body's immune system and then stimulate the immune system to destroy infections and cancers.

"The 21st Century Fund provides critical seed capital to emerging high-growth companies such as PDS Biotechnology that are necessary to ensure our state's economic growth," said Governor Mitch Daniels.

PDS Biotech's technology, which has already garnered financial support from the U.S. National Cancer Institute, will first appear in a therapy the company is developing aimed at combating currently incurable cancers associated with the human papilloma virus (HPV). Toxicology studies are underway now for the cancer-combating technology, and company officials plan to begin clinical trials in the next 18 months.

"This is a very exciting time for the company. The VersamuneTM technology has demonstrated the potential to overcome the key efficacy and safety obstacles associated with other leading technologies. PDS Biotechnology chose to locate the company in Indiana over other competing states based on several important factors including the presence of top-rated universities, a world-class nanotechnology center and the solid and rapidly growing biotechnology infrastructure," said Dr. Frank Bedu-Addo, president and chief executive officer of PDS Biotechnology Corporation.

The development of the therapy represents a breakthrough for treating HPV-related cancers. The virus is the most prevalent sexually transmitted agent worldwide and is present in nearly all cases of cervical cancer - the second leading cause of death in women worldwide.

The news of PDS relocating to Indiana comes less than three months after the U.S. National Cancer Institute's Nanotechnology Characterization Lab (NCL) announced it will collaborate with the firm to complete preclinical development of its HPV-cancer combating therapy. The NCL, a collaboration between the U.S. National Cancer Institute, the U.S. Food and Drug Administration and the National Institute of Standards and Technologies, will assist PDS Biotechnology in performing selected physical, chemical and biological studies to help speed the technology through regulatory submissions with the FDA.

PDS Biotech is one of 63 businesses awarded a 21st Century Fund grant since January 2006.

####

About Biotechnology Corporation
PDS Biotechnology Corporation is a biopharmaceutical company pioneering the development of safe, simple, potent and targeted immunotherapies for the treatment of cancer and infectious diseases. Unlike typical cancer and antiviral immunotherapies, the patented nanoparticle VersamuneTM technology both facilitates the uptake of disease-associated proteins and peptides by the cells of the immune system and simultaneously activates the immune system to generate a strong and specific immune response against the infected cells in the body, resulting in eradication of the cancer or viral disease.

About IEDC
Created by Governor Mitch Daniels in 2005 to replace the former Department of Commerce, the Indiana Economic Development Corporation is governed by a 12-member board chaired by Governor Daniels. Indiana Secretary of Commerce Mitch Roob serves as the chief executive officer of the IEDC. For more information about IEDC, visit www.iedc.in.gov.

For more information, please click here

Copyright © PDS Biotechnology Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

RMIT delivers $30m boost to micro and nano-tech August 26th, 2014

Creation of a Highly Efficient Technique to Develop Low-Friction Materials Which Are Drawing Attention in Association with Energy Issues August 26th, 2014

Competition for Graphene: Berkeley Lab Researchers Demonstrate Ultrafast Charge Transfer in New Family of 2D Semiconductors August 26th, 2014

Symphony of nanoplasmonic and optical resonators leads to magnificent laser-like light emission August 26th, 2014

Openings/New facilities/Groundbreaking/Expansion

RMIT delivers $30m boost to micro and nano-tech August 26th, 2014

Nanomedicine

Introducing the multi-tasking nanoparticle: Versatile particles offer a wide variety of diagnostic and therapeutic applications August 26th, 2014

Symphony of nanoplasmonic and optical resonators leads to magnificent laser-like light emission August 26th, 2014

Silver Replaced with Copper Nanoparticles to Produce Antibacterial Fabrics August 25th, 2014

Tissue regeneration using anti-inflammatory nanomolecules August 22nd, 2014

Announcements

RMIT delivers $30m boost to micro and nano-tech August 26th, 2014

Creation of a Highly Efficient Technique to Develop Low-Friction Materials Which Are Drawing Attention in Association with Energy Issues August 26th, 2014

Competition for Graphene: Berkeley Lab Researchers Demonstrate Ultrafast Charge Transfer in New Family of 2D Semiconductors August 26th, 2014

Symphony of nanoplasmonic and optical resonators leads to magnificent laser-like light emission August 26th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE